A multi-institution study of the accuracy of BRCAPRO in predicting BRCA1/BRCA2 mutations in women with ovarian cancer.
Molly S Daniels
No relevant relationships to disclose
Sheri Babb
No relevant relationships to disclose
Robin King
No relevant relationships to disclose
Diana Urbauer
No relevant relationships to disclose
Christopher I. Amos
No relevant relationships to disclose
Amanda C. Brandt
No relevant relationships to disclose
Adam Buchanan
No relevant relationships to disclose
David Gardner Mutch
No relevant relationships to disclose
Karen H. Lu
No relevant relationships to disclose